Order Article Reprints

Zeng T, Sun C, Liang Y, Yang F, Yan X, Bao S, Zhang Y, Huang X, Fu Z, Li W, et al. A Real-World Multicentre Retrospective Study of Low-Dose Apatinib for Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer. Cancers. 2022; 14(17):4084. https://doi.org/10.3390/cancers14174084

Zeng, Tianyu, Chunxiao Sun, Yan Liang, Fan Yang, Xueqi Yan, Shengnan Bao, Yucheng Zhang, Xiang Huang, Ziyi Fu, Wei Li, and et al. 2022. "A Real-World Multicentre Retrospective Study of Low-Dose Apatinib for Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer" Cancers 14, no. 17: 4084. https://doi.org/10.3390/cancers14174084

Zeng, T., Sun, C., Liang, Y., Yang, F., Yan, X., Bao, S., Zhang, Y., Huang, X., Fu, Z., Li, W., & Yin, Y. (2022). A Real-World Multicentre Retrospective Study of Low-Dose Apatinib for Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer. Cancers, 14(17), 4084. https://doi.org/10.3390/cancers14174084